Loading...
XHKG
1858
Market cap978mUSD
Jul 15, Last price  
13.92HKD
1D
5.14%
1Q
58.54%
Jan 2017
452.38%
IPO
-8.06%
Name

Beijing Chunlizhengda Medical Instruments Co Ltd

Chart & Performance

D1W1MN
P/E
25.25
P/S
5.81
EPS
0.50
Div Yield, %
3.51%
Shrs. gr., 5y
2.21%
Rev. gr., 5y
19.40%
Revenues
1.21b
+0.58%
98,094,696110,545,519134,534,445177,368,809207,926,096300,317,298497,927,159855,326,545937,686,1851,108,139,5201,201,604,2541,208,523,845
Net income
278m
-9.72%
31,939,63632,665,36137,031,19737,865,61763,440,59068,283,986105,646,070236,761,397283,373,280322,360,736307,719,145277,824,014
CFO
512m
+1,147.85%
28,827,96928,202,52724,274,585064,945,27289,833,114108,506,202231,540,264260,682,359164,785,78641,007,526511,713,888
Dividend
Jun 30, 20250.05247388 HKD/sh

Profile

Beijing Chunlizhengda Medical Instruments Co., Ltd., an orthopedic medical device company, engages in the research and development, production, and sale of surgical implants, instruments, and related products in the People's Republic of China. It offers implantable orthopedic medical devices, which consist of joint prosthesis products and spinal products. The company primarily sells its products through distributors, or on ODM and OEM bases under the Chunli brand, as well as to hospitals directly. It also exports its products to various countries. The company was incorporated in 1998 and is headquartered in Beijing, China.
URL
http://www.clzd.com/
IPO date
Dec 30, 2021
Employees
1,379
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,208,524
0.58%
1,201,604
8.43%
Cost of revenue
769,248
750,255
Unusual Expense (Income)
NOPBT
439,276
451,349
NOPBT Margin
36.35%
37.56%
Operating Taxes
28,088
29,161
Tax Rate
6.39%
6.46%
NOPAT
411,188
422,188
Net income
277,824
-9.72%
307,719
-4.54%
Dividends
(120,057)
Dividend yield
2.49%
Proceeds from repurchase of equity
1,939
BB yield
-0.03%
Debt
Debt current
1,221
688
Long-term debt
2,284
1,940
Deferred revenue
83,791
85,757
Other long-term liabilities
2
1
Net debt
(2,094,881)
(1,722,293)
Cash flow
Cash from operating activities
511,714
41,008
CAPEX
(33,242)
Cash from investing activities
(81,556)
Cash from financing activities
(121,334)
FCF
870,377
165,490
Balance
Cash
2,098,387
1,724,921
Long term investments
2
Excess cash
2,037,960
1,664,841
Stockholders' equity
1,834,436
1,521,012
Invested Capital
1,130,343
1,223,383
ROIC
34.94%
34.46%
ROCE
14.77%
16.40%
EV
Common stock shares outstanding
385,867
384,649
Price
12.50
-21.68%
15.96
5.42%
Market cap
4,823,334
-21.43%
6,138,997
16.98%
EV
2,730,221
4,416,704
EBITDA
473,931
481,383
EV/EBITDA
5.76
9.18
Interest
365
16,208
Interest/NOPBT
0.08%
3.59%